Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine, Quetiapine, and Risperidone in First Episode Psychosis
NCT00034892Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2002
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of olanzapine, quetiapine, risperidone in schizophrenia, schizophreniform disorder, schizoaffective disorder, sponsored by AstraZeneca. Started Mar 2002; status: completed.
02
Drugs
olanzapinequetiapinerisperidone
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorder
Beyond the preview
Go deeper on NCT00034892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034892.